ANNABELLE PANNELL: Open Payments
NPI 1316246242 · CLINTWOOD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$957 in 51 payments from 14 companies in 2025. Trend: 2023 $390 · 2024 $704 · 2025 $957
Food & beverage: $957
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $187 |
| ABBVIE INC. | 13 | $159 |
| Vanda Pharmaceuticals Inc. | 11 | $155 |
| PFIZER INC. | 9 | $141 |
| Novo Nordisk Inc | 3 | $81 |
| Janssen Pharmaceuticals, Inc | 1 | $46 |
| Amgen Inc. | 3 | $46 |
| Dexcom, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Insulet Corporation | 1 | $22 |
Products named: NURTEC ODT, QULIPTA, AIRSUPRA, BREZTRI, HETLIOZ, FANAPT, Ozempic, SPRAVATO.
Industry payments across VA — which companies pay providers there.
